Brief: Piramal Pharma March-Quarter Consol Net PAT Rises
May 10 (Reuters) - Piramal Pharma Ltd PIRM.NS :
* PIRAMAL PHARMA MARCH-QUARTER CONSOL NET PAT 1.01 BILLION
RUPEES
VERSUS PROFIT 501.1 MILLION RUPEES
* PIRAMAL PHARMA MARCH-QUARTER CONSOL REVENUE FROM
OPERATIONS
25.52 BILLION RUPEES VERSUS 21.64 BILLION RUPEES
Source text for Eikon: ID:
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington